Posts Tagged ‘CXD’

CathRX Signs European Distribution Agreement

Wednesday, June 17th, 2009

Cardiac catheter manufacturer CathRx Limited (CXD) and Medicor Medical Supplies (MMS) affiliate, Corizon GmbH announced today they have signed an agreement to distribute CathRx’s products to centres in Germany, Austria and Switzerland. Corizon is a specialist distributor which services the rapidly expanding cardiology/electrophysiology industry in the region. The agreement with Corizon will significantly expand CathRx’s distribution network. In addition to its own five specialists, Corizon can access into MMS’ network of over 20 field engineers located across the region.

Speaking about the agreement, Heinz Gerhards MMS’ Managing Director said, “The agreement with CathRx comes at an exciting time for us. The industry is expanding rapidly at the moment and we are pleased to be able to supply our specialised network with some of the most advanced products available today in Europe. We are very impressed by the innovations developed by the CathRx team, the products offer some unique features which we know are valued by our customers.” Speaking about the agreement, CathRx President, Ged Wallace said, “The addition of Corizon to our existing distribution networks will be a key underpinning in the achievement our sales targets. The agreement kicks off another major push into Europe including CathRx’s participation in Europace, the official Congress of the European Heart Rhythm Association.”

CathRx is a medical device company which manufactures and markets advanced cardiac catheter solutions for the treatment of people suffering from electrical problems of the heart known as cardiac arrhythmias. CathRx’s proprietary diagnostic and therapeutic catheters are designed to give physicians the tools to successfully treat patients with speed, safety and precision. CathRx’s first diagnostic products are now being sold in Europe.

www.cathrx.com

Post to Twitter

CathRX TO Commence Clinical Trials in Asutralia

Thursday, April 30th, 2009

Cardiac catheter manufacturer CathRx Limited (CXD) today announced the John Hunter Hospital had joined its Australian clinical trial to gather data for Australian Therapeutic Goods Administration (TGA) approval for its quadrapolar and decapolar diagnostic catheters. John Hunter Hospital is a leading teaching hospital and major cardiology and cardiac surgery centre. CathRx’s Australian approval trial began at Westmead Hospital in Sydney in November 2008. 

CathRx Chief Executive Officer Neil Anderson said that while the catheters had already been on sale in Europe, the Australian trial was being conducted to enable CathRx to file for Australian approvals. The protocol at John Hunter Hospital calls for use of CathRx’s diagnostic catheters undergoing electrophysiology procedures that require the use of diagnostic catheters. There will be an equal number of CathRx and control patients. The primary end-point is a confirmation of diagnostic capability. 

CathRx is a medical device company which manufactures and sells advanced cardiac catheter systems for the treatment of cardiac arrhythmias. CathRx’s proprietary diagnostic and therapeutic catheters are designed to give physicians the tools to successfully treat patients with speed, safety and precision. CathRx’s first diagnostic products are now on sale in Europe. 

www.cathrx.com.au

Post to Twitter